InsidersTradesSigma
Follow the 지투지바이오 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 지투지바이오 has published 8 insider filings. Market capitalisation: €618.8bn. The latest transaction was filed on 5 June 2026 (Purchase). Among the most active insiders: 이희용. All data is free.
6
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 June 2026
Declarations8 total
Other
Other
8 of 8 declarations
关于 지투지바이오
지투지바이오 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发创新的生物制药解决方案。